Ziosoft Receives FDA Clearance for CT Brain Perfusion A...( Brain perfus...),Health

Brain perfusion application is accessible to clinicians throughout the enterprise using the Ziostation® thin-client system.

Redwood City, Calif (PRWEB) January 8, 2009 -- Ziosoft®, Inc., a leader in advanced visualization and analysis software for medical imaging, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CT brain perfusion application.

The brain perfusion application is a powerful analysis tool used with the Ziostation thin-client system. The software is unique in its ability to provide brain perfusion functionality to clinicians as a thin-client application using standard commercial hardware. This software option aids radiologists in stroke assessment by providing a color map of cerebral blood flow and other perfusion-related parameters from CT images of the brain. The brain perfusion application includes image manipulation tools as well as measurement tools such as cerebral blood volume, blood flow and mean transit time. Ziosoft's brain perfusion application provides radiologists with decision support tools to accurately assess the type and extent of cerebral perfusion disturbance whether viewed in a hospital or at a remote location offering physicians flexibility and efficiency in viewing solutions.

"Because time to reach diagnosis and begin treatment for stroke victims is critical, we are pleased to provide this new brain perfusion application which can be accessed enterprise-wide," said Mark Koeniguer, Ziosoft's chief operating officer. "Results can also be accessed via a standard web-browser through Ziostation Web, demonstrating our commitment
'/>"/>